Vivus, Why the Slide? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Vivus, Why the Slide?

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: RT who wrote (3921)	9/25/1997 11:45:00 AM
From: Louis Riley	of 3991

I just spoke to spokesperson Ron Aldrige at Pfizer. First of all, there are NO analyst meetings scheduled for this month, contrary to what Maria Bartiromo reported this morning on CNBC. Don't believe everything you hear. However, there will be an analyst meeting on October 30 (well after VVUS' earnings report). PFE's heads of research will discuss the next 6 drugs in their pipeline, of which Viagra is one. They expect Viagra to be the biggest drug of the 6. They will file the NDA for Viagra by the end of this month. They will know how the FDA will treat the NDA soon after it is filed. If they get a "fast track" approval, the drug could be on the market by Q2 98. Otherwise, Q4 98 is more likely. They do not believe that the drug's side effects are severe enough to hinder approval. I asked him in particular about the vision side effects (makes some men see everything in blue) - they are continuing to monitor those patients that experienced those side effects. FWIW.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next